Ointments, skin creams and injections containing chondroitin sulfate used by people suffering from osteoarthritis is a key driver for the growth of the global chondroitin sulfate market as osteoarthritis is one of the most common forms of arthritis affecting 20 million people in the USA alone. Injecting a solution that contains chondroitin sulfate and sodium hyaluronate into the eye protects the eye during cataract surgery further increasing the usability of this product and driving the demand in the global chondroitin sulfate market. Another factor that drives the market is the increased adoption of pets, as chondroitin sulfate together with glucosamine is utilized as a part of the veterinary prescription.
In addition, it is used during cataract surgery, and as a solution for preserving corneas used for transplants. It is approved by the FDA for these uses. Chondroitin sulfate is also taken via mouth for HIV/AIDS, coronary illness, heart assault, muscle soreness after exercise and flaky skin (psoriasis). This is likely to boost the demand for chondroitin sulfate during the forecast period. Some chondroitin tablets may contain high levels of manganese, which could be problematic with long-term use. Other side effects may vary from person-to-person including diarrhea, constipation, and abdominal pain, bloating, diarrhea, constipation, headache, swollen eyelids, leg swelling, hair loss, skin rash, and irregular heartbeat. These factors are likely to hamper the growth of the global chondroitin sulfate market.
You can Get Free Sample Report Here @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2006